Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Sundry Debtors ₹40 Cr₹45 Cr₹41 Cr₹15 Cr₹9.56 Cr

What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?

The latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS is ₹40 Cr based on Mar2025 Standalone results.
Year Sundry Debtors
Mar2025₹40 Cr
Mar2024₹45 Cr
Mar2023₹41 Cr
Mar2022₹15 Cr
Mar2021₹9.56 Cr

How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2025 ₹40 Cr
-11.50
Mar2024 ₹45 Cr
10.32
Mar2023 ₹41 Cr
178.41
Mar2022 ₹15 Cr
54.60
Mar2021 ₹9.56 Cr -

Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹268.9 Cr -9.3% 3.3% 49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-9.3%

3.3%

49.4%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses